IBSA USA
Benjamin Platek is an accomplished human resources executive with extensive experience across various industries. Currently serving as Executive Director of Human Resources at Yaral Pharma and IBSA USA, Benjamin has previously held key HR leadership roles at IVI RMA Global, Brookfield Renewable, Jet Aviation, Summit Medical Group of New Jersey, Tradeweb, New Jersey Devils, GFI Group, and Madison Square Garden. Throughout a successful career, Benjamin has demonstrated expertise in HR strategy, employee engagement, talent acquisition, performance management, and diversity initiatives. An alumnus of Rutgers University with a Bachelor of Science in Management and Economics, Benjamin has consistently applied strategic human resource management to support organizational growth and foster positive workplace cultures.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.